206 related articles for article (PubMed ID: 33602720)
1. Modified Hypoxia-Inducible Factor Expression in CD8
Veliça P; Cunha PP; Vojnovic N; Foskolou IP; Bargiela D; Gojkovic M; Rundqvist H; Johnson RS
Cancer Immunol Res; 2021 Apr; 9(4):401-414. PubMed ID: 33602720
[TBL] [Abstract][Full Text] [Related]
2. Hypoxia enhances CD8
Ning F; Takeda K; Schedel M; Domenico J; Joetham A; Gelfand EW
J Allergy Clin Immunol; 2019 Jun; 143(6):2026-2037.e7. PubMed ID: 30660639
[TBL] [Abstract][Full Text] [Related]
3. Hypoxia-inducible factor activity promotes antitumor effector function and tissue residency by CD8+ T cells.
Liikanen I; Lauhan C; Quon S; Omilusik K; Phan AT; Bartrolí LB; Ferry A; Goulding J; Chen J; Scott-Browne JP; Yustein JT; Scharping NE; Witherden DA; Goldrath AW
J Clin Invest; 2021 Apr; 131(7):. PubMed ID: 33792560
[TBL] [Abstract][Full Text] [Related]
4. Sprouty2 Protein Regulates Hypoxia-inducible Factor-α (HIFα) Protein Levels and Transcription of HIFα-responsive Genes.
Hicks KC; Patel TB
J Biol Chem; 2016 Aug; 291(32):16787-801. PubMed ID: 27281823
[TBL] [Abstract][Full Text] [Related]
5. HIF1α or HIF2α: Enhancing CD8
Chen J
Cancer Immunol Res; 2021 Apr; 9(4):364. PubMed ID: 34003767
[TBL] [Abstract][Full Text] [Related]
6. The HIF-1α hypoxia response in tumor-infiltrating T lymphocytes induces functional CD137 (4-1BB) for immunotherapy.
Palazón A; Martínez-Forero I; Teijeira A; Morales-Kastresana A; Alfaro C; Sanmamed MF; Perez-Gracia JL; Peñuelas I; Hervás-Stubbs S; Rouzaut A; de Landázuri MO; Jure-Kunkel M; Aragonés J; Melero I
Cancer Discov; 2012 Jul; 2(7):608-23. PubMed ID: 22719018
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia-inducing factor (HIF)-1α-derived peptide capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24
Minami T; Matsumura N; Sugimoto K; Shimizu N; De Velasco M; Nozawa M; Yoshimura K; Harashima N; Harada M; Uemura H
Int Immunopharmacol; 2017 Mar; 44():197-202. PubMed ID: 28110220
[TBL] [Abstract][Full Text] [Related]
8. Decursin promotes HIF-1α proteasomal degradation and immune responses in hypoxic tumour microenvironment.
Ge Y; Yoon SH; Jang H; Jeong JH; Lee YM
Phytomedicine; 2020 Nov; 78():153318. PubMed ID: 32896707
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia-inducible factors enhance the effector responses of CD8(+) T cells to persistent antigen.
Doedens AL; Phan AT; Stradner MH; Fujimoto JK; Nguyen JV; Yang E; Johnson RS; Goldrath AW
Nat Immunol; 2013 Nov; 14(11):1173-82. PubMed ID: 24076634
[TBL] [Abstract][Full Text] [Related]
10. A
Kjaergaard J; Hatfield S; Jones G; Ohta A; Sitkovsky M
J Immunol; 2018 Jul; 201(2):782-791. PubMed ID: 29802128
[TBL] [Abstract][Full Text] [Related]
11. Gramicidin A blocks tumor growth and angiogenesis through inhibition of hypoxia-inducible factor in renal cell carcinoma.
David JM; Owens TA; Inge LJ; Bremner RM; Rajasekaran AK
Mol Cancer Ther; 2014 Apr; 13(4):788-99. PubMed ID: 24493697
[TBL] [Abstract][Full Text] [Related]
12. Anti-VEGF Treatment Enhances CD8
de Almeida PE; Mak J; Hernandez G; Jesudason R; Herault A; Javinal V; Borneo J; Kim JM; Walsh KB
Cancer Immunol Res; 2020 Jun; 8(6):806-818. PubMed ID: 32238381
[TBL] [Abstract][Full Text] [Related]
13. Enhanced HIF2α expression during human trophoblast differentiation into syncytiotrophoblast suppresses transcription of placental growth factor.
Fujii T; Nagamatsu T; Morita K; Schust DJ; Iriyama T; Komatsu A; Osuga Y; Fujii T
Sci Rep; 2017 Sep; 7(1):12455. PubMed ID: 28963486
[TBL] [Abstract][Full Text] [Related]
14. Identification of the hypoxia-inducible factor 2α nuclear interactome in melanoma cells reveals master proteins involved in melanoma development.
Steunou AL; Ducoux-Petit M; Lazar I; Monsarrat B; Erard M; Muller C; Clottes E; Burlet-Schiltz O; Nieto L
Mol Cell Proteomics; 2013 Mar; 12(3):736-48. PubMed ID: 23275444
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia inducible factor signaling in breast tumors controls spontaneous tumor dissemination in a site-specific manner.
Todd VM; Vecchi LA; Clements ME; Snow KP; Ontko CD; Himmel L; Pinelli C; Rafat M; Johnson RW
Commun Biol; 2021 Sep; 4(1):1122. PubMed ID: 34556788
[TBL] [Abstract][Full Text] [Related]
16. Gene transfer of antisense hypoxia inducible factor-1 alpha enhances the therapeutic efficacy of cancer immunotherapy.
Sun X; Kanwar JR; Leung E; Lehnert K; Wang D; Krissansen GW
Gene Ther; 2001 Apr; 8(8):638-45. PubMed ID: 11320410
[TBL] [Abstract][Full Text] [Related]
17. Differential Contribution of N- and C-Terminal Regions of HIF1α and HIF2α to Their Target Gene Selectivity.
Bouthelier A; Meléndez-Rodríguez F; Urrutia AA; Aragonés J
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33321829
[TBL] [Abstract][Full Text] [Related]
18. The hypoxia-inducible factor 2alpha N-terminal and C-terminal transactivation domains cooperate to promote renal tumorigenesis in vivo.
Yan Q; Bartz S; Mao M; Li L; Kaelin WG
Mol Cell Biol; 2007 Mar; 27(6):2092-102. PubMed ID: 17220275
[TBL] [Abstract][Full Text] [Related]
19. Ex vivo culture with interleukin (IL)-12 improves CD8(+) T-cell adoptive immunotherapy for murine leukemia independent of IL-18 or IFN-gamma but requires perforin.
Macgregor JN; Li Q; Chang AE; Braun TM; Hughes DP; McDonagh KT
Cancer Res; 2006 May; 66(9):4913-21. PubMed ID: 16651448
[TBL] [Abstract][Full Text] [Related]
20. HIF transcription factors, inflammation, and immunity.
Palazon A; Goldrath AW; Nizet V; Johnson RS
Immunity; 2014 Oct; 41(4):518-28. PubMed ID: 25367569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
